CRP and rheumatoid arthritis: In the intra-group comparisons of the RA and PsA groups, 6th-month DAS-28 CRP scores were found to be statistically significantly higher in those with polypharmacy at the 6th month of treatment than in those without polypharmacy at the 6th month of treatment (p = 0.048 and p = 0.005, respectively).